The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 20, 2025

Filed:

Mar. 30, 2020
Applicant:

Primegene (Beijing) Co., Ltd., Beijing, CN;

Inventors:

Wei Wu, Beijing, CN;

Li Zhu, Beijing, CN;

Yanqing Yang, Beijing, CN;

Wei Hu, Beijing, CN;

Hui Zhang, Beijing, CN;

Changxin Dong, Beijing, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/12 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); C07D 215/22 (2006.01); C07D 215/233 (2006.01); C07D 401/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07D 215/22 (2013.01); C07D 409/12 (2013.01); C07D 417/12 (2013.01);
Abstract

Provided is a quinolyl-containing compound as shown in general formula (I) or (II) or a pharmaceutically acceptable salt, a solvate, an active metabolite, a polymorph, an isotopic label, or an isomer thereof, and further provided are a pharmaceutical composition comprising the compound and use of the compound and the pharmaceutical composition. The provided compound has a dual molecule function, can serve as multi-target inhibitors of novel tyrosine kinase/histone deacetylase, can simultaneously achieve the effect of two inhibitors, has excellent biological activity and pharmacokinetic properties, and has the application potential particularly in the field of treatment of tumors.


Find Patent Forward Citations

Loading…